Navigating Colorado’s Evolving Innovation Landscape: Investment Trends, Talent Development, and Emerging Market Opportunities in CRE

What You’ll Learn From CRE Leaders At This Event:

• How has venture capital driven the growth of Colorado’s life sciences ecosystem, particularly with the $2.15B raised in 2024, marking a 46% increase from 2023?
• With $52.9B in contributions to Colorado’s economy from life sciences, how does the sector impact the state’s overall economic health?
• How has Denver-Boulder’s life sciences talent pool- ranked 11th for R&D, 16th for manufacturing and 18th for Medtech– contributed to the region’s position as a leading hub for innovation in these subsectors?
• Given that life sciences project costs have risen by 20-25% since the pandemic, how are CRE professionals in Denver-Boulder adapting to these increased cost pressures?
• What considerations should developers in Denver-Boulder keep in mind when planning future life sciences facilities, particularly around the flexibility required for evolving technologies?

SPEAKERS

Elyse Blazevich – President and CEO, CBSA
Kelly Brough – CEO, Fitzsimons Innovation
Afshin Safavi – CEO, Colorado Health & Tech Centers
Eve Lieberman – Executive Director, OEDIT, State of Colorado
Praful Shah – Angel Investor
Emma Martin – Chief of Staff, AOA Dx
Adam Diffendal – Project Executive, Swinerton

Learn More + Register

Discount Code: CBSAVIP